ONL Therapeutics

ONL Therapeutics

A biopharmaceutical company developing therapies to preserve sight of patients with retinal disease

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
ONL Therapeutics, Inc. funding round, August 2019
3,000,000
August 2019
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Hirak Parikh

Investor

James Murray

Investor

John Freshley

Board member

John Freshley

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.